| 000 | 00940 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518085145.0 | ||
| 264 | 0 | _c20210831 | |
| 008 | 202108s 0 0 eng d | ||
| 022 | _a1421-9751 | ||
| 024 | 7 |
_a10.1159/000506151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKunutsor, Setor K | |
| 245 | 0 | 0 |
_aHeart Failure Risk Reduction: Hydrophilic or Lipophilic Statins? _h[electronic resource] |
| 260 |
_bCardiology _c2020 |
||
| 300 |
_a384-386 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRisk Reduction Behavior |
| 700 | 1 | _aLaukkanen, Jari A | |
| 773 | 0 |
_tCardiology _gvol. 145 _gno. 6 _gp. 384-386 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000506151 _zAvailable from publisher's website |
| 999 |
_c30650755 _d30650755 |
||